DIETARY_SUPPLEMENT · Unmapped registry intervention
Docosahexaenoic acid (DHA)
Find medicine records ·
Find other trials using this name
Clinical trial
Docosahexaenoic Acid (DHA) for Women With Breast Cancer in the Neoadjuvant Setting
NCT03831178
Drugs and interventions used in this trial
2 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
DRUG · Unmapped registry intervention
Placebo oral capsule
Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedDocosahexaenoic Acid (DHA) for Women With Breast Cancer in the Neoadjuvant Setting
Design: INTERVENTIONAL · Status: ACTIVE NOT RECRUITING · Phase: PHASE2
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Breast Cancerverified · MONDO: breast cancer
Interventions
Docosahexaenoic acid (DHA)DIETARY_SUPPLEMENT
Sponsors & collaborators
AHS Cancer Control Albertalead sponsor
Canadian Institutes of Health Research (CIHR)collaborator
University of Albertacollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT03831178 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.